Publication | Closed Access

Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA

InflammationE-cadherin/β-catenin PathwayMicrobial PathogensMucosal ImmunologyImmunologyGut BarrierUlcerative ColitisColitis-to-cancer TransitionMedicineCell BiologyCell SignalingTumor BiologyBanxia Xiexin Decoction